NCT03968900

Brief Summary

The number one preventable cause of death in the world is tobacco use. Cigarette smoking in particular, costs an estimated $300 billion due to expenses related to medical care and lost productivity. Despite similar smoking prevalence rates, blacks suffer disproportionately from smoking-related harms compared to whites.Sleep disparities such as shortened sleep duration, shorter circadian periodicity, earlier chronotype, and increased variability of sleep timing have been reported more frequently in blacks compared to whites. Given that poor sleep quality predicts relapse from smoking cessation programs, particularly among socioeconomically disadvantaged adults, sleep deficiencies and irregular timing of sleep may impact smoking craving and withdrawal symptoms over the course of the 24-hour day. Surprisingly, few studies have examined these temporal patterns of smoking and craving, and none with regard to sleep disruption, chronotype or racial disparities. A better understanding of these factors may explain heterogeneity within the smoking population, especially in minorities. Thus, the purpose of this proposal is to test the central hypothesis that the impact of chronotype and impaired sleep on cigarette usage as well as smoking dependence, urge/craving, and withdrawal depends on race.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jan 2021Aug 2026

First Submitted

Initial submission to the registry

May 23, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

August 8, 2025

Status Verified

August 1, 2025

Enrollment Period

4.2 years

First QC Date

May 23, 2019

Last Update Submit

August 4, 2025

Conditions

Keywords

smokingsleep deficienciessocioeconomic disadvantageRace

Outcome Measures

Primary Outcomes (1)

  • Sleep Hygiene Index

    A 13-item scale that assesses behaviors, such as variability in wake-time, timing of physical activity, and substance use, that comprise sleep hygiene 0: Never (Best) 1. Rarely 2. Sometimes 3. Frequent 4. Always (Worst)

    6 months

Secondary Outcomes (9)

  • Pittsburgh Sleep Quality Index

    6 months

  • Munich Chronotype Questionnaire

    6 months

  • Fagerström Test for Nicotine Dependence

    6 months

  • Snoring history, Tired during the day, Observed stop breathing while sleep, High blood pressure, BMI more than 35 kg/m2, Age more than 50 years, Neck circumference more than 40 cm and male Gender (STOP-BANG) Questionnaire

    6 months

  • Insomnia Severity Index

    6 months

  • +4 more secondary outcomes

Other Outcomes (17)

  • Duke- The University of North Carolina at Chapel Hill (UNC) Functional Social Support Questionnaire (FSSQ)

    6 months

  • Patient Health Questionnaire (PHQ-9)

    6 months

  • Generalized Anxiety Disorder (GAD-7)

    6 months

  • +14 more other outcomes

Study Arms (2)

Sleep Restriction

EXPERIMENTAL

4 hours time in bed (1 am to 5 am)

Behavioral: Sleep restriction condition

Sleep Extension

EXPERIMENTAL

10 hours time in bed (10 pm to 8 am)

Behavioral: Sleep extension condition

Interventions

On day 1, participants will complete study assessments and will be fitted with an Actiwatch and instructed to continue a fixed time in bed (8 hours duration with no more than 20 min deviation) centered on habitual sleep (e.g., 11:00 p.m. to 7:00 a.m.). Naps will not be allowed. Following the one-week baseline sleep stabilization, participants will engage in the sleep restriction condition (4 hours, TIB \[Time in Bed\]; 1:00 a.m. to 5:00 a.m.). On the day of each sleep study, participants will be admitted to University of Alabama Birmingham (UAB) Highlands Hospital sleep unit at 7:00 p.m. and do an initial CO breathe test and fill out study questionnaires and a timeline follow-back procedure Participants will monitored for smoking withdrawal. Every 2 hours, participants to fill out various questionnaires. Participants will repeat the same conditions as the first night. After a two-week washout, participants will be crossed over to the alternate sleep extension/restriction condition.

Sleep Restriction

sleep extension On day 1, participants will complete study assessments and will be fitted with an Actiwatch and instructed to continue a fixed time in bed (8 hours duration with no more than 20 min deviation) centered on habitual sleep (e.g., 11:00 p.m. to 7:00 a.m.). Naps will not be allowed. Following the one-week baseline sleep stabilization, participants will engage in the sleep extension condition (10 hours, (TIB); 10:00 p.m. to 8:00 a.m.). On the day of each sleep study, participants will be admitted to University of Alabama Birmingham Highlands Hospital sleep unit at 7:00 p.m. and do an initial CO breathe test and fill out study questionnaires and a timeline follow-back procedure Participants will monitored for smoking withdrawal. Every 2 hours, participants to fill out various questionnaires. Participants will repeat the same conditions as the first night. After a two-week washout, participants will be crossed over to the alternate sleep extension/restriction condition.

Sleep Extension

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Able to read and speak English
  • Non-Hispanic African American (Black) or non-Hispanic white race
  • Daily smoker (5 or more cigarettes a day for the past one year and having smoked more than 100 cigarettes in lifetime) or non-smoker (smoked fewer than 100 cigarettes in a lifetime and no smoking-not even a puff- in the last year)
  • Currently residing in Alabama

You may not qualify if:

  • Non-English speaking
  • Lives in restricted environment that does not allow smoking
  • Pregnant or lactating
  • Currently receiving smoking cessation treatment or using electronic cigarettes or other tobacco to try and quit smoking cigarettes
  • Participants would work outside normal 7 a.m. to 6 p.m. hours
  • Former smokers
  • Sub-study 2
  • years or older
  • Able to read and speak English
  • Non-Hispanic African American (Black) or non-Hispanic white race
  • Daily smoker defined as smoking 5 or more cigarettes a day for the past one year and having smoked more than 100 cigarettes in lifetime, as well as by an expired Carbon Monoxide (CO )cut-off of Carbon Monoxide (CO)\>10ppm and positive cotinine test to ensure daily smoking OR non-smoker defined as smoking fewer than 100 cigarettes in a lifetime and no smoking-not even a puff- in the last year, as well as by an expired Carbon monoxide (CO) cut-off of Carbon Monoxide (CO)\<3 ppm and negative cotinine test.
  • Currently residing in Alabama
  • Non-English speaking
  • Lives in restricted environment that does not allow smoking
  • Pregnant or lactating
  • +30 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama, Birmingham

Birmingham, Alabama, 35226, United States

Location

MeSH Terms

Conditions

SmokingParasomniasTobacco Use Disorder

Condition Hierarchy (Ancestors)

BehaviorSleep Wake DisordersNervous System DiseasesMental DisordersSubstance-Related DisordersChemically-Induced Disorders

Study Officials

  • Karen L Cropsey, Psy.D.

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 23, 2019

First Posted

May 30, 2019

Study Start

January 1, 2021

Primary Completion

April 1, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

August 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations